{"database": "openregs", "table": "documents", "rows": [["FDA-2015-P-3404-0004", "FDA", "FDA-2015-P-3404", "Determination That LIPTRUZET (Ezetimibe and Atorvastatin) Tablets,\n10 Milligrams/10 Milligrams, 10 Milligrams/20 Milligrams, 10\nMilligrams/40 Milligrams, and 10 Milligrams/80 Milligrams, Were Not\nWithdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2015-11-20T05:00:00Z", 2015, 11, "2015-11-20T05:00:00Z", null, "2015-12-01T20:22:32Z", "2015-29639", 0, 0, "0900006481d5e0b2"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-P-3404-0004"], "units": {}, "query_ms": 8.354068966582417, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}